Home

Ind-swift Laboratories Ltd EPS

Image

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

EPS

₹ 14

Last updated on: Apr 02, 2025

Key Highlights

  • The Earning per Share of Ind-Swift Laboratories Ltd is ₹ 14 as of 02 Apr 25 .
  • The earning per share of Ind-Swift Laboratories Ltd changed from ₹ 2.92 to ₹ 0 over 7 quarters. This represents a CAGR of -100.00% .

Historical Earning per Share of Ind-Swift Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Ind-Swift Laboratories Ltd

Market Cap

529 Cr

EPS

14.0

P/E Ratio (TTM)

6.4

P/B Ratio (TTM)

0.5

Day’s High

93.77

Day’s Low

87.77

DTE

0.0

ROE

10.1

52 Week High

186.0

52 Week Low

81.68

ROCE

13.3

Market Price of Ind-Swift Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ind-Swift Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 202589.56
01 Apr 202590.82
28 Mar 202583.98
27 Mar 202585.63
26 Mar 202585.62
25 Mar 202588.81
24 Mar 202593.02
21 Mar 202593.04
20 Mar 202593.34
19 Mar 202593.31

SWOT Analysis Of Ind-Swift Laboratories Ltd

Strength

5

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Ind-Swift Laboratories Ltd

Asset Value vs Market Value of Ind-Swift Laboratories Ltd

Market Value

529

-0.2 X

Value addition

Asset Value

693

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Ind-Swift Laboratories Ltd529.18
Sun Pharmaceutical Industries Ltd411306
Divis Laboratories Ltd150343
Cipla Ltd117323
Torrent Pharmaceuticals Ltd108614
Mankind Pharma Ltd99891

Historical Market Cap of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Ind-Swift Laboratories Ltd News Hub

Ind-Swift Laboratories consolidated net profit declines 94.55% in the June 2024 quarter

Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024

Read more

13 Aug 24

Ind-Swift Laboratories standalone net profit declines 63.70% in the June 2024 quarter

Net profit of Ind-Swift Laboratories declined 63.70% to Rs 6.19 crore in the quarter ended June 2024

Read more

13 Aug 24

Ind-Swift Laboratories to discuss results

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 202

Read more

03 Aug 24

Ind-Swift Laboratories to hold AGM

Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held o

Read more

03 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Ind-Swift Laboratories Ltd

What is the EPS of Ind-Swift Laboratories Ltd stock?

The Earnings Per Share (EPS) of Ind-Swift Laboratories Ltd is 14.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Ind-Swift Laboratories Ltd EPS calculated?

The EPS of Ind-Swift Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ind-Swift Laboratories Ltd report its EPS?

Ind-Swift Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ind-Swift Laboratories Ltd EPS?

Factors that influence the EPS of Ind-Swift Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ind-Swift Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Ind-Swift Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions